# Jin Kyung Rho

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jin-kyung-rho/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,824 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 29 |
| i10-index | 62 |
| Last Known Institution | Ulsan College |
| OpenAlex ID | https://openalex.org/A5067969008 |
| ORCID iD | 0000-0003-3918-0099 |
| Works | 153 |

## Researcher papers

- [Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer](https://scholariq.org/papers/activation-of-the-axl-kinase-causes-resistance-to-egfr-targeted-therapy-in-lung/)
- [Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer](https://scholariq.org/papers/exosomal-pd-l1-promotes-tumor-growth-through-immune-escape-in-non-small-cell/)
- [RETRACTED ARTICLE: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers](https://scholariq.org/papers/retracted-article-egfr-and-met-receptor-tyrosine-kinase-altered-microrna/)
- [Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line](https://scholariq.org/papers/epithelial-to-mesenchymal-transition-derived-from-repeated-exposure-to-gefitinib/)
- [Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells](https://scholariq.org/papers/upregulation-of-cxcr4-is-functionally-crucial-for-maintenance-of-stemness-in/)
- [Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs](https://scholariq.org/papers/clinical-and-molecular-evidences-of-epithelial-to-mesenchymal-transition-in/)
- [MET and AXL Inhibitor NPS-1034 Exerts Efficacy against Lung Cancer Cells Resistant to EGFR Kinase Inhibitors Because of MET or AXL Activation](https://scholariq.org/papers/met-and-axl-inhibitor-nps-1034-exerts-efficacy-against-lung-cancer-cells/)
- [p53 Enhances Gefitinib-Induced Growth Inhibition and Apoptosis by Regulation of Fas in Non–Small Cell Lung Cancer](https://scholariq.org/papers/p53-enhances-gefitinib-induced-growth-inhibition-and-apoptosis-by-regulation-of/)
- [Epithelial‐mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4‐ALK translocation](https://scholariq.org/papers/epithelial-mesenchymal-transition-leads-to-crizotinib-resistance-in-h2228-lung/)
- [Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4](https://scholariq.org/papers/tumor-derived-exosomal-mir-619-5p-promotes-tumor-angiogenesis-and-metastasis/)
- [Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice](https://scholariq.org/papers/efficacy-safety-and-resistance-profile-of-osimertinib-in-t790m-mutation-positive/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [Phagocytosis and Immune Regulation](https://scholariq.org/topics/phagocytosis-and-immune-regulation/)

## Researcher university

- [Ulsan College](https://scholariq.org/institutions/ulsan-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.